메뉴 건너뛰기
Indian Journal of Medical and Paediatric Oncology
Volumn 34, Issue 3, 2013, Pages 154-158
Chronic myeloid leukemia data from India
Author keywords

Chronic myeloid leukemia; India; Indian cooperative oncology network; mylestone
Indexed keywords

GENERIC DRUG; IMATINIB;
EID: 84891845227     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.123711     Document Type: Review
Times cited : (28)
References (8)
  • 1
    • 0034489987 scopus 로고    scopus 로고
    • Chronic myelogenous leukaemia
    • Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000;111:993-1009
    • (2000) Br J Haematol , vol.111 , pp. 993-1009
    • Lee, S.J.1
  • 2
    • 0038518619 scopus 로고    scopus 로고
    • Practical management of patients with chronic myeloid leukemia receiving imatinib
    • Deininger MW, O?Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003;21:1637-47
    • (2003) J Clin Oncol , vol.21 , pp. 1637-1647
    • Deininger, M.W.1    Obrien, S.G.2    Ford, J.M.3    Druker, B.J.4
  • 3
    • 79952534340 scopus 로고    scopus 로고
    • Modern therapy of chronic myeloid leukemia: An example for paradigma shift in Hematooncology
    • Leitner AA, Hehlmann R. Modern therapy of chronic myeloid leukemia: an example for paradigma shift in Hematooncology. Internist (Berl).2011;52:209-17
    • (2011) Internist (Berl) , vol.52 , pp. 209-217
    • Leitner, A.A.1    Hehlmann, R.2
  • 4
    • 68549097002 scopus 로고    scopus 로고
    • International randomized study of interferon versus STI571 (IRIS) 7-year followup: Sustained survival low rate of transformation and increased rate of major molecular response (MMR) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib (IM)
    • O?Brien SG, Guilhot F, Goldman JM, Hochhaus A, Hughes TP, Radich JP, et al. International randomized study of interferon versus STI571 (IRIS) 7-year followup: Sustained survival, low rate of transformation and increased rate of major molecular response (MMR) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib (IM). Blood 2008;112:76
    • (2008) Blood , vol.112 , pp. 76
    • Obrien, S.G.1    Guilhot, F.2    Goldman, J.M.3    Hochhaus, A.4    Hughes, T.P.5    Radich, J.P.6
  • 5
    • 73349122639 scopus 로고    scopus 로고
    • Chronic myeloid leukemia: An update of concepts and management recommendations of European LeukemiaNet
    • Last accessed on 2013 nov 6
    • Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: An update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009;27:6041-51. Available from: http://www.oncologyindia.org/myelstone/. Last accessed on 2013 nov 6
    • (2009) J Clin Oncol , vol.27 , pp. 6041-6051
    • Baccarani, M.1    Cortes, J.2    Pane, F.3    Niederwieser, D.4    Saglio, G.5    Apperley, J.6
  • 6
    • 84891852799 scopus 로고    scopus 로고
    • In Kumar L (Editor): Progress in Hematologic Oncology. Pub. The Advanced Research Foundation New York, New York
    • Bhutani M and Kochupillai V. Hematological malignancies in India, in Kumar L (editor): Progress in Hematologic Oncology. Pub. The Advanced Research Foundation New York, New York 2003, p10
    • (2003) Hematological malignancies in India , vol.10
    • Bhutani, M.1    Kochupillai, V.2
  • 8
    • 71949114529 scopus 로고    scopus 로고
    • Chronic myelogenous leukemia
    • In Padzur R, Coia LR, Hoskins WJ,Wagman LD (eds). Cancer Management: A multidisciplinary approach. 10th ed. Lawrence
    • Cortes JE, Richard TS, Hagop K. Chronic myelogenous leukemia. In: Padzur R, Coia LR, Hoskins WJ,Wagman LD (eds). Cancer Management: A multidisciplinary approach. 10th ed. Lawrence: CMPMedica; 2007. p.789.
    • (2007) CMPMedica , pp. 789
    • Cortes, J.E.1    Richard, T.S.2    Hagop, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.